Description: CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. CRISPR-Cas9 system is being used in microbial genome editing, mammalian genome editing, disease models, and more. It has shown potential in human disease treatment. However, it is not easy to find CRISPR-Cas systems genome editing in a single source. This volume offers CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome editing, viral disease, protozoan disease, fungal disease, stem cell therapy, CRISPR in epigenetics, CRISPR in cancer, autoimmune and blood disorders. In addition, it highlights a number of aspects of the CRISPR-Cas systems that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and stakeholders to perform their research with great interest.
Price: 236 AUD
Location: Hillsdale, NSW
End Time: 2025-01-27T17:22:47.000Z
Shipping Cost: 24.99 AUD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
Returns Accepted: Returns Accepted
Item must be returned within: 30 Days
Return policy details:
EAN: 9780443315886
UPC: 9780443315886
ISBN: 9780443315886
MPN: N/A
Format: Hardback, 308 pages
Author: Vijay Singh (Volume editor)
Item Height: 15.2 cm
Item Weight: 0.45 kg
Item Width: 22.9 cm
Language: Eng
Publication Name: N/A
Publisher: Academic Press Inc
Type: N/A
